Navigation Links
Angiotech Pharmaceuticals Announces Conference Call and Webcast
Date:2/4/2010

Fourth Quarter and Year End 2009 Financial Results

VANCOUVER, Feb. 4 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ( ANPI, TSX: ANP) will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2009, on Thursday, March 4, 2010 at 9:00 AM ET (6:00 AM PT).

Dial-in information for the earnings call on March 4, 2010 is as follows:

North America (toll-free): 866.770.7129

International: 617.213.8067

Enter Passcode: 69484239

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investors section.

A press release announcing Angiotech's financial results will be issued prior to the call on March 4th at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until March 11, 2010.

Replay information is as follows:

North America (toll-free): 888.286.8010

International: 617.801.6888

Enter Passcode: 61713924

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech ( ANPI, TSX: ANP), please visit our website at www.angiotech.com.

SOURCE Angiotech Pharmaceuticals, Inc.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
3. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
4. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
5. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
6. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
7. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
8. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
9. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
10. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
11. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics ... of foodborne pathogens,  today announced that Mary Duseau , ... Convention on March 29 at 9:50am ET. The conference will ... About Roka Bioscience ... Roka Bioscience is a molecular diagnostics ...
(Date:3/27/2017)... , March 27, 2017 Cousins Properties (NYSE: ... world,s leading biotechnology companies, has signed a 10-year, approximately 125,000 ... A office asset located in the Westshore submarket of ... thrilled that Amgen has chosen Corporate Center for their new ... Gellerstedt , president and chief executive officer of Cousins Properties. ...
(Date:3/27/2017)... MOSCOW , March 27, 2017 Infectex Ltd., a Russian ... Phase 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in ... by scientists at Sequella, Inc. ( USA ) and the US National ... ... Maxwell Biotech Venture Fund Logo ...
(Date:3/27/2017)... , March 27, 2017  Perthera,s Chief Bioinformatics Officer ... Subha Madhavan , Ph.D., will be speaking at ... Panels. On Monday, March 27, 2017, she will be ... More Usable for Research and Care" (from 10:30 a.m. ... 2017, she will be a participant in the "Making ...
Breaking Biology Technology:
(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/2/2017)... , March 2, 2017 Summary ... understand Perrigo and its partnering interests and activities since 2010. ... Read ... Deals and Alliance since 2010 report provides an in-depth insight ... life sciences companies. On demand company reports are ...
Breaking Biology News(10 mins):